Cardiovascular and safety events of PCSK9 inhibitors in statin-treated patients with cardiovascular risk: A Systematic Review and Meta-Analysis.

Zhao, Zinan; Hu, Xin; Zhang, Yatong; Liu, Deping

Zhao, Zinan; Hu, Xin; Zhang, Yatong; Liu, Deping.

Affiliation

Zhao Z; beijing hospital.

J Pharm Pharm Sci ; 23: 422-436, 2020.

Article in En | MEDLINE | ID: mdl-33137282

Subject(s)

Cardiovascular Diseases/drug therapy; Hypolipidemic Agents/administration & dosage; PCSK9 Inhibitors; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects; Hypolipidemic Agents/adverse effects; Hypolipidemic Agents/pharmacology; Randomized Controlled Trials as Topic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cardiovascular Diseases / PCSK9 Inhibitors / Hypolipidemic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google